LabCorp to expand oncology offerings with $1.2 billion Chiltern buy: Reuters

Diagnostics company Laboratory Corp of America Holdings (LH.N) said on Monday it would buy privately owned contract research organization (CRO) Chiltern International Ltd for nearly $1.2 billion in cash to expand its oncology offerings.

31 July 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles